Prevalence of Peripartum Cardiomyopathy in Pre-Eclampsia Patients Presenting To a Tertiary Care Health Facility
Abstract
Objective: To determine the frequency of Peripartum cardiomyopathy (PPCM) in Pre-eclamptic women presenting to a tertiary care facility.
Methodology: This descriptive cross-sectional study was conducted over a period of six months, from December 9, 2021, to June 10, 2022, in the Gynecology and Obstetrics Unit I of Liaquat University Hospital, Hyderabad. The study population comprised preeclampsia women aged 18 to 45 years, with a gestational age of more than 20 weeks as confirmed by early ultrasound, regardless of parity, and carrying a single alive fetus. PPCM was diagnosed based on echocardiographic findings, with the key diagnostic criterion being a left ventricular ejection fraction (LVEF) of less than 45%.
Results: Of 102 patients, the mean age of the patients was 25.57 ±3.73 years. The mean height, weight, and BMI of the patients were 160.11 ±8.89 cm, 75.09 ±14.82 kg, and 29.08 ±5.19 kg/m2 respectively. The mean 24 hours proteinuria level of the patients was 344.62 ±16.35 mg/24 hours. The mean ejection fraction was found to be 55.01 ±9.69%. Frequency of PPCM was observed in 9 (9%) patients, which was statistically insignificant according to age, residential status, BMI and mode of delivery (>0.05).
Conclusion: PPCM was concluded to be 9% among pre-eclamptic women, highlighting a notable association between pre-eclampsia and the development of cardiac dysfunction during the peripartum period, which underscoring the need for enhanced clinical observation and routine cardiovascular assessment in this population.
Copyright (c) 2025 Journal of The Society of Obstetricians and Gynaecologists of Pakistan

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.